2.84
Theratechnologies Inc stock is traded at $2.84, with a volume of 327.87K.
It is down -0.87% in the last 24 hours and up +102.86% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$2.865
Open:
$2.86
24h Volume:
327.87K
Relative Volume:
0.12
Market Cap:
$124.15M
Revenue:
$84.32M
Net Income/Loss:
$-3.16M
P/E Ratio:
-56.80
EPS:
-0.05
Net Cash Flow:
$-4.50M
1W Performance:
+5.19%
1M Performance:
+102.86%
6M Performance:
+134.71%
1Y Performance:
+118.46%
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
THTX
Theratechnologies Inc
|
2.84 | 124.15M | 84.32M | -3.16M | -4.50M | -0.05 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
509.50 | 126.59B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
598.76 | 64.27B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
645.14 | 36.31B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
263.24 | 31.32B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
104.15 | 27.60B | 2.98B | -717.57M | -264.74M | -2.9987 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
(TH) Stock Market Analysis (TH:CA) - news.stocktradersdaily.com
(TH) Advanced Trading Insights (TH:CA) - news.stocktradersdaily.com
(TH) Pivots Trading Plans and Risk Controls (TH:CA) - news.stocktradersdaily.com
Is Theratechnologies Inc. (THTX) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
Theratechnologies to further evaluate potential sale of company - MSN
Theratechnologies: A High-Risk, High-Reward Speculation As Shares Trade At 39% Discount To Future Pak's $3.51-$4.50 Offer (NASDAQ:THTX) - Seeking Alpha
What is Leede Financial’s Forecast for THTX FY2025 Earnings? - Defense World
Theratechnologies Evaluates Potential Sale Amid Future Pak Proposal - TipRanks
Theratechnologies (THTX) Explores Sale Amid Ongoing Discussions - GuruFocus
Theratechnologies (THTX) Explores Potential Sale Amidst Future P - GuruFocus
Theratechnologies Provides Update on Sale Process - GlobeNewswire
Major Acquisition Alert: Theratechnologies Opens Sale Process Following Buyout Interest - Stock Titan
Theratechnologies Engages in Exclusive Acquisition Talks - TipRanks
Theratechnologies Provides Update on Sale Process | THTX Stock N - GuruFocus
Soleus Capital Urges Theratechnologies (THTX) Acquisition - GuruFocus
Theratechnologies can do better than the Future Pak offer, Leede says - Cantech Letter
Crude Oil Moves Lower; M&T Bank Earnings Miss Views - Benzinga
Trend Tracker for (TH) (TH:CA) - news.stocktradersdaily.com
Analyst Reveals Undervalued Pharmaceutical Gem in Canada - streetwisereports.com
Future Pak submits proposals to acquire Theratechnologies - MSN
Theratechnologies Hits 52-Week High As Acquisition Talks Heat Up - Finimize
Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News
Theratechnologies in talks with anonymous potential buyer while fielding Future Pak buyout offer - PharmaLive
Theratechnologies in Talks with Anonymous Potential Buyer While Fielding Future Pak Buyout Offer - BioSpace
Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak - Fierce Pharma
Future Pak Proposes Acquisition of Theratechnologies (THTX) - GuruFocus
Theratechnologies (THTX) Urged to Consider Acquisition Offer by Soleus Capital | THTX Stock News - GuruFocus
Soleus Capital Issues Letter to The Board of Theratechnologies - citybiz
Soleus Capital issues letter to board of Theratechnologies - MSN
Theratechnologies Hits New High After Deflecting Acquisition Attempts - Finimize
Theratechnologies (THTX) Soars Amid Acquisition Proposals - GuruFocus
Theratechnologies Responds to Future Pak's Press Release and Ann - GuruFocus
Soleus Capital Urges Theratechnologies Board To Accept Acquisition Offer From Future Pak - Nasdaq
Theratechnologies (THTX) Upgraded to Buy Amid Acquisition Buzz | THTX Stock News - GuruFocus
Soleus Capital Issues Letter to The Board of Theratechnologies | THTX Stock News - GuruFocus
Theratechnologies (THTX) Eyes Growth with New Acquisitions - GuruFocus
Theratechnologies (THTX) Surges as Future Pak Proposes Acquisiti - GuruFocus
Future Pak Submits Proposals to Acquire Theratechnologies Inc., - GuruFocus
Theratechnologies stock soars on acquisition offer - Investing.com Australia
Theratechnologies (THTX) Explores Acquisition Proposals - GuruFocus
MSP Recovery And Theratechnologies Shine With Massive Trading Volumes - Finimize
Canadian drug developer Theratechnologies becomes takeover target - The Globe and Mail
(TH) Strategic Market Analysis (TH:CA) - news.stocktradersdaily.com
Future Pak to Acquire Theratechnologies in High-Stakes $255M Bid - USA Herald
Theratechnologies Engages in Exclusive Acquisition Talks Amid Future Pak Proposals - TipRanks
Theratechnologies Responds to Future Pak’s Press Release - GlobeNewswire
Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions - Bluefield Daily Telegraph
Acquisition Battle Heats Up: Theratechnologies Reveals New Exclusive Buyer After $100M Offer - Stock Titan
Future Pak Goes Public With $255M Theratechnologies Bid - Law360
Theratechnologies: Buy Rating Upgrade Amid EGRIFTA Developments and Acquisition Interest - TipRanks
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):